Form D · Biotechnology

BIOTELEMETRY, INC.

Malvern, PA · CIK 0001574774

Offering snapshot reported Mar 15, 2019 · SEC filing

Reported sold
$0
Indefinite offering
Investors reported
114
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 1, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2019Initial$0No comparison114SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-335038
Total amts offered/sold not known or calculable at this time; amts determined after 3-yr earn-out & performance-based at $67.85/share. Min earn-out $20m. Merger consideration paid at clsg $45m cash.
Right to receive shares of common stock after 3 year "earn-out period"; underlying shares of common stock at earn-out.

Source: Form D, filed Mar 15, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fred Broadway Executive
Joseph H. Capper Director, Executive
Anthony James Conti Director
Laura Dietch Director
Peter Ferola Executive
Joseph A. Frick Director
Heather C. Getz Executive
Kirk Gorman Director
Colin Hill Director
Tiffany Olson Director
Stephan Rietiker Director
Rebecca W. Rimel Director
Robert J. Rubin Director
Daniel Wisniewski Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1000 Cedar Hollow Road
Malvern, PA, 19355